AbbVie (ABBV) Earnings Date, Estimates & Call Transcripts → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free ABBV Stock Alerts $161.24 +4.93 (+3.15%) (As of 05/31/2024 08:50 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateJul. 25EstimatedActual EPS (May. 3) $2.31 Beat By $0.05 Consensus EPS (May. 3) $2.26 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get AbbVie Earnings AlertsEnter your email address below to receive the latest news and earnings results for ABBV and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueABBV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABBV Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution AbbVie Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244$2.21$10.93$4.402.180 - 2.220Q2 20244$2.98$12.20$5.323.050 - 3.090Q3 20244$2.86$13.31$5.49 Q4 20244$3.02$14.29$5.85 FY 202416$11.07$50.73$21.05 Q1 20251$2.73$2.73$2.73 Q2 20251$2.98$2.98$2.98 Q3 20251$3.04$3.04$3.04 Q4 20251$3.30$3.30$3.30 FY 20254$12.05$12.05$12.05 Q1 20261$2.96$2.96$2.96 ABBV Earnings Date and InformationAbbVie last issued its earnings data on May 3rd, 2024. The reported $2.31 earnings per share for the quarter, topping the consensus estimate of $2.26 by $0.05. The business earned $12.31 billion during the quarter, compared to analyst estimates of $11.93 billion. Its revenue was up .7% on a year-over-year basis. AbbVie has generated $3.37 earnings per share over the last year ($3.37 diluted earnings per share) and currently has a price-to-earnings ratio of 47.8. Earnings for AbbVie are expected to grow by 7.28% in the coming year, from $11.26 to $12.08 per share. AbbVie has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off prior year's report dates.Read More AbbVie Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/25/2024(Estimated)------- 5/3/2024Q1 2024$2.26$2.31+$0.05$3.85$11.93 billion$12.31 billion 2/2/2024Q4 2023$2.76$2.79+$0.03$5.12$14.02 billion$14.30 billion 10/27/2023Q3 2023$2.86$2.95+$0.09$4.90$13.72 billion$13.93 billion 7/27/2023Q2 2023$2.79$2.91+$0.12$4.68$13.52 billion$13.87 billion4/27/2023Q1 2023$2.44$2.46+$0.02$4.79$12.23 billion$12.23 billion 2/9/2023Q4 2022$3.54$3.60+$0.06$5.82$15.30 billion$15.12 billion Get the Latest News and Ratings for ABBV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbbVie and its competitors with MarketBeat's FREE daily newsletter. 10/28/2022Q3 2022$3.56$3.66+$0.10$5.11$14.95 billion$14.81 billion 7/29/2022Q2 2022$3.42$3.51+$0.09$6.51$14.64 billion$14.58 billion 4/29/2022Q1 2022$3.15$3.16+$0.01$3.81$13.61 billion$13.36 billion 2/2/2022Q4 2021$3.29$3.31+$0.02$4.36$14.96 billion$14.89 billion 10/28/2021Q3 2021$3.22$3.33+$0.11$4.88$14.30 billion$14.34 billion 7/29/2021Q2 2021$3.09$3.11+$0.02$5.80$13.64 billion$13.96 billion 4/29/2021Q1 2021$2.83$2.95+$0.12$3.91$12.84 billion$13.01 billion 2/2/2021Q4 2020$2.85$2.92+$0.07$5.83$13.70 billion$13.86 billion 10/30/2020Q3 2020$2.75$2.83+$0.08$4.37$12.71 billion$12.88 billion 7/31/2020Q2 2020$2.20$2.34+$0.14$5.14$10.14 billion$10.43 billion 5/1/2020Q1 2020$2.25$2.42+$0.17$2.82$8.31 billion$8.62 billion 2/7/2020Q4 2019$2.19$2.21+$0.02$2.54$8.68 billion$8.70 billion 11/1/2019Q3 2019$2.29$2.33+$0.04$3.40$8.37 billion$8.48 billion 7/26/2019Q2 2019$2.21$2.26+$0.05$4.03$8.09 billion$8.26 billion AbbVie Earnings - Frequently Asked Questions When is AbbVie's earnings date? AbbVie has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off last year's report dates. Learn more on ABBV's earnings history. Did AbbVie beat their earnings estimates last quarter? In the previous quarter, AbbVie (NYSE:ABBV) reported $2.31 earnings per share (EPS) to beat the analysts' consensus estimate of $2.26 by $0.05. Learn more on analysts' earnings estimate vs. ABBV's actual earnings. How can I listen to AbbVie's earnings conference call? The conference call for AbbVie's latest earnings report can be listened to online. Listen to Conference Call How can I read AbbVie's conference call transcript? The conference call transcript for AbbVie's latest earnings report can be read online. Read Transcript How can I view AbbVie's earnings report? AbbVie's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded annual revenue of $54.32 billion. How much profit does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded net income of $4.86 billion. ABBV has generated $3.37 earnings per share over the last four quarters. What is AbbVie's price-to-earnings ratio? AbbVie (NYSE:ABBV) has a trailing price-to-earnings ratio of 47.85 and a forward price-to-earnings ratio of 14.32. The price/earnings-to-growth ratio is 2.06. What is AbbVie's EPS forecast for next year? AbbVie's earnings are expected to grow from $11.26 per share to $12.08 per share in the next year, which is a 7.28% increase. More Earnings Resources from MarketBeat Related Companies: Amgen Earnings Results Gilead Sciences Earnings Results Moderna Earnings Results Seagen Earnings Results IDEXX Laboratories Earnings Results IQVIA Earnings Results BioNTech Earnings Results Illumina Earnings Results Janux Therapeutics Earnings Results Eli Lilly and Company Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: ZIM Shipping Stock Forecast, Earnings Triggers a BuyHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of Buyers This page (NYSE:ABBV) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldAlert: Your Bank is Dying – Act Now or Lose Everything!Priority GoldNext President (Not Trump. Not Biden.)The Freeport SocietyWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHistoric Crash Could Wipe Away Your 401k (Govt Debt Explosion)Birch GoldPrepare for a Recession Unlike Any OtherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.